Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial protein thiol groups and enzymes represent a broad class of targets for various antimicrobial agents, particularly antiseptics and disinfectants. These targets consist of the sulfhydryl (-SH) functional groups found on cysteine residues within essential bacterial proteins and enzymes involved in metabolism and cellular maintenance (StatPearls, 2023). When these groups are targeted by agents such as heavy metals (e.g., silver or mercury) or oxidizing agents, the resulting covalent modification or cross-linking leads to the inactivation of critical metabolic pathways and the denaturation of structural proteins (Goodman & Gilman, 12th Ed.). This multi-target approach is highly effective at inhibiting bacterial growth and causing cell death across a wide range of species, including many multi-drug resistant organisms (PubMed, 11030311). However, because thiol groups are also ubiquitous in human proteins, the therapeutic use of such agents is generally restricted to topical applications to minimize systemic toxicity. Modern clinical use is primarily seen in wound care, burn treatment, and ophthalmic preparations where localized action is desired (NCBI, PMC7062457).
Antimicrobial agents, particularly heavy metals and certain antiseptics, interact by forming covalent bonds or mercaptides with the sulfhydryl (-SH) groups of bacterial enzymes and structural proteins. This interaction leads to the inactivation of essential metabolic enzymes, such as those in the respiratory chain, and causes protein denaturation and precipitation, ultimately resulting in bacterial cell death (StatPearls, 2023; Goodman & Gilman, 12th Ed.).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial protein thiol groups and enzymes.